Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

E4F1 controls a transcriptional program essential for pyruvate dehydrogenase activity.

Lacroix M, Rodier G, Kirsh O, Houles T, Delpech H, Seyran B, Gayte L, Casas F, Pessemesse L, Heuillet M, Bellvert F, Portais JC, Berthet C, Bernex F, Brivet M, Boutron A, Le Cam L, Sardet C.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10998-1003. doi: 10.1073/pnas.1602754113. Epub 2016 Sep 12.

2.

NMI mediates transcription-independent ARF regulation in response to cellular stresses.

Li Z, Hou J, Sun L, Wen T, Wang L, Zhao X, Xie Q, Zhang SQ.

Mol Biol Cell. 2012 Dec;23(23):4635-46. doi: 10.1091/mbc.E12-04-0304. Epub 2012 Oct 3.

3.

E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cells.

Hatchi E, Rodier G, Lacroix M, Caramel J, Kirsh O, Jacquet C, Schrepfer E, Lagarrigue S, Linares LK, Lledo G, Tondeur S, Dubus P, Sardet C, Le Cam L.

J Exp Med. 2011 Jul 4;208(7):1403-17. doi: 10.1084/jem.20101995. Epub 2011 Jun 27.

4.

Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis.

Lacroix M, Caramel J, Goguet-Rubio P, Linares LK, Estrach S, Hatchi E, Rodier G, Lledo G, de Bettignies C, Thépot A, Deraison C, Chébli K, Hovnanian A, Hainaut P, Dubus P, Sardet C, Le Cam L.

Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21076-81. doi: 10.1073/pnas.1010167107. Epub 2010 Nov 18. Erratum in: Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14716.

5.

The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Song MS, Song SJ, Kim SY, Oh HJ, Lim DS.

EMBO J. 2008 Jul 9;27(13):1863-74. doi: 10.1038/emboj.2008.115. Epub 2008 Jun 19.

6.

Therapeutic targets in the ARF tumor suppressor pathway.

Saporita AJ, Maggi LB Jr, Apicelli AJ, Weber JD.

Curr Med Chem. 2007;14(17):1815-27. Review.

7.

The role of LANP and ataxin 1 in E4F-mediated transcriptional repression.

Cvetanovic M, Rooney RJ, Garcia JJ, Toporovskaya N, Zoghbi HY, Opal P.

EMBO Rep. 2007 Jul;8(7):671-7. Epub 2007 Jun 8.

8.

Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.

Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW, Quelle DE.

Mol Cell Biol. 2005 Feb;25(4):1258-71.

9.

E4F1, a novel estrogen-responsive gene in possible atheroprotection, revealed by microarray analysis.

Nakamura Y, Igarashi K, Suzuki T, Kanno J, Inoue T, Tazawa C, Saruta M, Ando T, Moriyama N, Furukawa T, Ono M, Moriya T, Ito K, Saito H, Ishibashi T, Takahashi S, Yamada S, Sasano H.

Am J Pathol. 2004 Dec;165(6):2019-31.

10.

Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family.

Calabrò V, Mansueto G, Santoro R, Gentilella A, Pollice A, Ghioni P, Guerrini L, La Mantia G.

Mol Cell Biol. 2004 Oct;24(19):8529-40.

11.

The E4F protein is required for mitotic progression during embryonic cell cycles.

Le Cam L, Lacroix M, Ciemerych MA, Sardet C, Sicinski P.

Mol Cell Biol. 2004 Jul;24(14):6467-75.

12.

Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2.

Tessari MA, Gostissa M, Altamura S, Sgarra R, Rustighi A, Salvagno C, Caretti G, Imbriano C, Mantovani R, Del Sal G, Giancotti V, Manfioletti G.

Mol Cell Biol. 2003 Dec;23(24):9104-16.

Supplemental Content

Support Center